Familial hypercholesterolaemia: Underdiagnosed and undertreated

European Heart Journal

Volumn 29, Issue 21, 2008, Pages 2583-2584

  Rees, Alan ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID SEQUESTRANT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID;

EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; FATALITY; GENOTYPE; GROWTH DISORDER; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION;

AGE FACTORS; CORONARY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; PRACTICE GUIDELINES AS TOPIC;

EID: 55749083573     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn448     Document Type: Editorial

References (7)

1. National Institute for Health and Clinical Excellence. Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. 2008 (Clinical guidelines 71) www.nice.org.uk/CG71
2. Wierzbicki AS, Humphries SE, Minhas R on behalf of the Guideline Development Group. Familial hypercholesterolaemia: summary of NICE guidance. BMJ 2008;337:509-510.
3. Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 1991;303:893-896.
4. Betteridge DJ, Broome K, Durrington PN, Hawkins MM, Humphries SE, Mann JI, Miller JP, Neil HAW, Thompson GR, Thorogood M, Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 1999;142:105-112.
5. Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries S on behalf of the Simon Broome Familial Hyperlipidaemia Register Group. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008;29:2625-2633. First published on October 7, 2008. doi:10.1093/eurheartj/ehn422.
6. Neil HAW, Huxxley R, Hawkins MM, Durrington PN, Betteridge DJ, Humphries SE for the Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee. Comparison of fatal coronary mortality in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: results of a registry study. Atherosclerosis 2003;170:73-78.
7. Karp I, Behlouli H, LeLorier J, Pilote L. Statins and cancer risk. Am J Med 2008;121:302-309